Literature DB >> 35058322

The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging.

Philip Sutera1, Ryan M Phillips2, Matthew Deek3, Gokhan Ozyigit4, Cem Onal5, Phuoc T Tran6,7.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35058322      PMCID： PMC8978198          DOI： 10.2967/jnumed.121.263684

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  15 in total

1.  Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.

Authors:  Marlon Perera; Nathan Papa; Matthew Roberts; Michael Williams; Cristian Udovicich; Ian Vela; Daniel Christidis; Damien Bolton; Michael S Hofman; Nathan Lawrentschuk; Declan G Murphy
Journal:  Eur Urol       Date:  2019-02-14       Impact factor: 20.096

2.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

3.  Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

Authors:  Daniel R Gomez; Chad Tang; Jianjun Zhang; George R Blumenschein; Mike Hernandez; J Jack Lee; Rong Ye; David A Palma; Alexander V Louie; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; James W Welsh; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Anne S Tsao; Boris Sepesi; Stephen G Swisher; John V Heymach
Journal:  J Clin Oncol       Date:  2019-05-08       Impact factor: 44.544

4.  Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections.

Authors:  Nicola Fossati; Simone Scarcella; Giorgio Gandaglia; Nazareno Suardi; Daniele Robesti; Luca Boeri; R Jeffrey Karnes; Axel Heidenreich; David Pfister; Alexander Kretschmer; Alexander Buchner; Christian Stief; Antonino Battaglia; Steven Joniau; Hendrik Van Poppel; Daniar Osmonov; Klaus-Peter Juenemann; Shahrokh Shariat; Andreas Hiester; Alessandro Nini; Peter Albers; Derya Tilki; Markus Graefen; Inderbir S Gill; Alexander Mottrie; Andrea Benedetto Galosi; Francesco Montorsi; Alberto Briganti
Journal:  J Urol       Date:  2020-02-18       Impact factor: 7.450

5.  Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness.

Authors:  Rosario Mazzola; Giulio Francolini; Luca Triggiani; Giuseppe Napoli; Francesco Cuccia; Luca Nicosia; Lorenzo Livi; Stefano Maria Magrini; Matteo Salgarello; Filippo Alongi
Journal:  Clin Genitourin Cancer       Date:  2020-08-06       Impact factor: 2.872

Review 6.  Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.

Authors:  Matthias Guckenberger; Yolande Lievens; Angelique B Bouma; Laurence Collette; Andre Dekker; Nandita M deSouza; Anne-Marie C Dingemans; Beatrice Fournier; Coen Hurkmans; Frédéric E Lecouvet; Icro Meattini; Alejandra Méndez Romero; Umberto Ricardi; Nicola S Russell; Daniel H Schanne; Marta Scorsetti; Bertrand Tombal; Dirk Verellen; Christine Verfaillie; Piet Ost
Journal:  Lancet Oncol       Date:  2020-01       Impact factor: 41.316

7.  Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

Authors:  Puneeth Iyengar; Zabi Wardak; David E Gerber; Vasu Tumati; Chul Ahn; Randall S Hughes; Jonathan E Dowell; Naga Cheedella; Lucien Nedzi; Kenneth D Westover; Suprabha Pulipparacharuvil; Hak Choy; Robert D Timmerman
Journal:  JAMA Oncol       Date:  2018-01-11       Impact factor: 31.777

8.  Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.

Authors:  Rachel M Glicksman; Ur Metser; Douglass Vines; John Valliant; Zhihui Liu; Peter W Chung; Robert G Bristow; Antonio Finelli; Robert Hamilton; Neil E Fleshner; Nathan Perlis; Alexandre R Zlotta; David Green; Andrew Bayley; Joelle Helou; Srinivas Raman; Girish Kulkarni; Charles Catton; Tony Lam; Rosanna Chan; Padraig Warde; Mary Gospodarowicz; David A Jaffray; Alejandro Berlin
Journal:  Eur Urol       Date:  2021-03-06       Impact factor: 20.096

9.  PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer.

Authors:  Charlotte L Deijen; Gerbert L Vrijenhoek; Eva E Schaake; Wouter V Vogel; Luc M F Moonen; Floris J Pos; Henk G van der Poel; Gerben R Borst
Journal:  Clin Transl Radiat Oncol       Date:  2021-06-29

10.  Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.

Authors:  Ryan Phillips; William Yue Shi; Matthew Deek; Noura Radwan; Su Jin Lim; Emmanuel S Antonarakis; Steven P Rowe; Ashley E Ross; Michael A Gorin; Curtiland Deville; Stephen C Greco; Hailun Wang; Samuel R Denmeade; Channing J Paller; Shirl Dipasquale; Theodore L DeWeese; Daniel Y Song; Hao Wang; Michael A Carducci; Kenneth J Pienta; Martin G Pomper; Adam P Dicker; Mario A Eisenberger; Ash A Alizadeh; Maximilian Diehn; Phuoc T Tran
Journal:  JAMA Oncol       Date:  2020-05-01       Impact factor: 31.777
View more
  1 in total

Review 1.  Defining Oligometastatic Disease in the New Era of PSMA-PET Imaging for Primary Staging of Prostate Cancer.

Authors:  Samuel J Galgano; Andrew M McDonald; Janelle T West; Soroush Rais-Bahrami
Journal:  Cancers (Basel)       Date:  2022-07-06       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.